PPMC’s former MD, Suleiman Achimugu Is Nigeria’s First COVID-19 Casualty

0 1,001

Today, Nigeria recorded her first death from the deadly novel coronavirus at the early hours of Monday in Abuja, the nation’s capital.

The Nigeria Center for Disease Control (NCDC) released a statement in a tweet today where it said

“The case was a 67-year-old male who returned home following medical treatment in the  UK.

“He had underlying medical conditions- multiple myeloma & diabetes & was undergoing chemotherapy

“Our thoughts are with his family.”

READ ALSO: Coronavirus 5G Conspiracy Theory, Keri Hilson Claimed.

Investigation revealed that the person involved was the 67-year-old former PPMC Managing Director, Suleiman Achimugu.

According to reports, Achimugu arrived in Nigeria two weeks ago, he was reported to have gone for medical treatment in the United Kingdom, he was suffering from multiple myeloma & diabetes and was reportedly undergoing chemotherapy.

The former MD was reported to show symptoms of the disease on Tuesday and the family claims that they contacted NCDC who went to his house to collect blood samples, but NCDC never turned up after that and by Sunday he had started having bouts of cough attacks, the worried family then contacted NCDC again to know the results of the blood samples that they collected earlier, that was when the family was informed that the result was positive.

Achimugu was immediately rushed to Gwagwalada general hospital and at about 2 am on Monday, he died.

His family members are not happy with the health authorities because of their delay in informing them about his health status considering that they took his blood samples early enough.

Following his death, members of his family have been confined to their house on quarantine, and we have been reliably informed that efforts are on to identify those who have had direct contact with the family since his return from the UK two weeks ago.

You might also like

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More